Cargando…
Risk for opioid misuse in chronic pain patients is associated with endogenous opioid system dysregulation
µ-Opioid receptors (MOR) are a major target of endogenous and exogenous opioids, including opioid pain medications. The µ-opioid neurotransmitter system is heavily implicated in the pathophysiology of chronic pain and opioid use disorder and, as such, central measures of µ-opioid system functioning...
Autores principales: | Ballester, Javier, Baker, Anne K., Martikainen, Ilkka K., Koppelmans, Vincent, Zubieta, Jon-Kar, Love, Tiffany M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755811/ https://www.ncbi.nlm.nih.gov/pubmed/35022382 http://dx.doi.org/10.1038/s41398-021-01775-z |
Ejemplares similares
-
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
por: Peciña, Marta, et al.
Publicado: (2018) -
Immediate Effects of tDCS on the μ-Opioid System of a Chronic Pain Patient
por: DosSantos, Marcos Fabio, et al.
Publicado: (2012) -
Pain Experiences and Their Relation to Opioid Misuse Risk and Emotion Dysregulation
por: Nauser, Jonathan W., et al.
Publicado: (2020) -
Building up Analgesia in Humans via the Endogenous μ-Opioid System by Combining Placebo and Active tDCS: A Preliminary Report
por: DosSantos, Marcos F., et al.
Publicado: (2014) -
A Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid System
por: Massaly, Nicolas, et al.
Publicado: (2016)